This contradicts previous findings that CPT1A overexpression accelerates ROS production by increasing fatty acid β-oxidation, thereby promoting ageing phenotypes or augmenting cancer cells’ oxidative defences (Jiang et al., 2022; Joshi et al., 2020; Luo et al., 2021). Here, CPT1A is linked to cancer.